Key statistics
As of last trade, Elicio Therapeutics Inc (ELTX:NAQ) traded at 5.09, 71.96% above the 52 week low of 2.96 set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.92 |
---|---|
High | 5.11 |
Low | 4.92 |
Bid | 5.02 |
Offer | 5.15 |
Previous close | 5.12 |
Average volume | 37.97k |
---|---|
Shares outstanding | 10.77m |
Free float | 7.96m |
P/E (TTM) | -- |
Market cap | 55.17m USD |
EPS (TTM) | -4.95 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 20:31 GMT.
More ▼
- Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
- Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
- Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit
- Elicio Therapeutics Reports Inducement Grants
- Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
- Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
- Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
- Elicio Therapeutics Announces Proposed Public Offering
More ▼